Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
DAVID R EBSWORTH Insider Profile
4 Followers
DAVID R EBSWORTH, Director at Verona Pharma, holds 844.64K shares in Verona Pharma (Ticker: VRNA). Most recently, DAVID R EBSWORTH Bought $160,000 shares of Verona Pharma on Nov 08, 2023 for an estimated value of 315.20K.
DAVID R EBSWORTH has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of DAVID R EBSWORTH's holdings
Insider Roles
Director
Roles that DAVID R EBSWORTH holds in companies
Most Profitable Insider Trade
The most profitable trade made by DAVID R EBSWORTH
DAVID R EBSWORTH's Trading History
List of latest transactions for each holding click on a transaction to see DAVID R EBSWORTH's performance on stock
You May Also Like
DAVID R EBSWORTH insider profile FAQ
What is the percentage of profitable transactions made by DAVID R EBSWORTH?
The percentage of profitable transactions made by DAVID R EBSWORTH is ―.
What is the average return per transaction made by DAVID R EBSWORTH?
The average return per transaction made by DAVID R EBSWORTH is ―.
What stocks does DAVID R EBSWORTH hold?
DAVID R EBSWORTH holds: VRNA stocks.
What was DAVID R EBSWORTH’s latest transaction?
DAVID R EBSWORTH latest transaction was an Informative Buy of $315.20K.
What was DAVID R EBSWORTH's most profitable transaction?
DAVID R EBSWORTH’s most profitable transaction was an Informative Buy of VRNA stock on November 8, 2023. The return on the trade was 11.10%.
What is DAVID R EBSWORTH's role in Verona Pharma?
DAVID R EBSWORTH's role in Verona Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.